Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Deferred Taxes: 2009-2025

Historic Deferred Taxes for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $17.4 million.

  • Prestige Consumer Healthcare's Deferred Taxes rose 363.33% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.3 million, marking a year-over-year increase of 87.75%. This contributed to the annual value of $14.4 million for FY2025, which is 37.54% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Deferred Taxes stood at $17.4 million for Q3 2025, which was up 198.34% from $5.8 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Deferred Taxes ranged from a high of $17.4 million in Q3 2025 and a low of -$74.8 million during Q1 2023.
  • In the last 3 years, Prestige Consumer Healthcare's Deferred Taxes had a median value of $5.2 million in 2023 and averaged -$1.3 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Deferred Taxes crashed by 5,578.51% in 2023, and later surged by 852.12% in 2025.
  • Prestige Consumer Healthcare's Deferred Taxes (Quarterly) stood at $3.7 million in 2021, then skyrocketed by 168.25% to $9.8 million in 2022, then slumped by 47.29% to $5.2 million in 2023, then plummeted by 43.65% to $2.9 million in 2024, then skyrocketed by 363.33% to $17.4 million in 2025.
  • Its Deferred Taxes was $17.4 million in Q3 2025, compared to $5.8 million in Q2 2025 and $7.1 million in Q1 2025.